Hikma Pharmaceutical | HIK - Current Liabilities

Stock Price
1,544.00
Daily Change
-7.00 -0.45%
Monthly
1.11%
Yearly
-32.04%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $2.06B in Current Liabilities for its fiscal semester ending in June of 2025.





Current Liabilities Change Date
Almirall EUR 298.52M 54.91M Jun/2025
argenx SE USD 1.04B 371.99M Jun/2025
AstraZeneca USD 34.05B 518M Sep/2025
Autolus Therapeutics Ltd USD 83.07M 14.92M Sep/2025
Bayer EUR 28.96B 825M Sep/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Galapagos EUR 366.56M 36.39M Sep/2025
Genmab DKK 629M 127M Jun/2025
GlaxoSmithKline GBP 21.33B 956M Sep/2025
GRIFOLS EUR 2.15B 164.7M Sep/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
Lonza CHF 3.58B 970M Dec/2024
Merck EUR 8.64B 1.22B Sep/2025
Orion EUR 550.5M 9.7M Sep/2025
Recordati EUR 1.04B 24.44M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
UCB EUR 3.53B 731M Dec/2024